Half-year report · HY
6894.TEDINET S100X3FK
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥972m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥89m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥56m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥100m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥354m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥53m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥100m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥39m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥71m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥356m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥71m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥25m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥4.8bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥5.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥963m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥283m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥153m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥157m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥144m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥375m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥247m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥152m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥159m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥154m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥51.83 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥260.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.55 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.7% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Healthcare Related Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥265m |
| Healthcare Related Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥265m |
| Healthcare Related Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥130,000 |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥397m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥397m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥100m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥379m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥379m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥136m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥236m |
| Healthcare Related Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥375m |
| Healthcare Related Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥375m |
| Healthcare Related Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥37m |
| Optical Applications And Special Customized Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥353m |
| Optical Applications And Special Customized Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥353m |
| Optical Applications And Special Customized Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥100m |
| X Ray Residual Stress Analyzerreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥244m |
| X Ray Residual Stress Analyzerreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥244m |
| X Ray Residual Stress Analyzerreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥972m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥207m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 417
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | Prior1InterimDuration | -175703000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration | -159756000 | JPY |
| Purchase of intangible assets inv cf | Prior1InterimDuration | -1270000 | JPY |
| Purchase of intangible assets inv cf | InterimDuration | － | JPY |
| Other net inv cf | Prior1InterimDuration | 119000 | JPY |
| Other net inv cf | InterimDuration | 729000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -246972000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -144004000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -5160000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -2660000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | -144000 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -47000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -148361000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -149556000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -153665000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -152263000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -12992000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | -229000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -570869000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -13850000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2267271000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1884027000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 1696402000 | JPY |
| Cash and cash equivalents | InterimInstant | 1870177000 | JPY |
| Payroll and allowances sga | Prior1InterimDuration | 86089000 | JPY |
| Payroll and allowances sga | InterimDuration | 106569000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 12968000 | JPY |
| Provision for bonuses sga | InterimDuration | 18446000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 5109000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 5839000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 243574000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 374769000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 353164000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 971509000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02021-000HealthcareRelatedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 243574000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 374769000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 353164000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 971509000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 69515000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 37038000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 100322000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 206876000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 379429000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02021-000HealthcareRelatedProductsReportableSegmentMember | 264525000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 397071000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 1041027000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |